Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002

Drug and Alcohol Dependence

Volumn 90, Issue 2-3, 2007, Pages 252-260

  Blanco, Carlos ^a   Alderson, Donald ^a   Ogburn, Elizabeth ^a   Grant, Bridget F ^b   Nunes, Edward V ^a   Hatzenbuehler, Mark L ^a   Hasin, Deborah S ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Epidemiology; NESARC; Prescription drug abuse; Prevalence trends

Indexed keywords

ADULT; ARTICLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADOLESCENT; ADULT; FEMALE; HUMANS; INCIDENCE; MALE; PRESCRIPTIONS, DRUG; PREVALENCE; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 34548025851     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.04.005     Document Type: Article

References (39)

1. American Academy of Pain Medicine the American Pain Society. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin. J. Pain 13 (1997) 6-8
2. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
3. Barker M.J., Greenwood K.M., Jackson M., and Crowe S.F. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 18 (2004) 37-48
4. Canino G., Bravo M., Ramirez R., Febo V., Fernandez R., Hasin D., and Grant B.F. The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. J. Stud. Alcohol. 60 (1999) 790-799
5. The National Center on Addiction and Substance Abuse (CASA), 2005. Under the counter: the diversion and abuse of controlled prescription drugs in the US. The National Center on Addiction and Substance Abuse at Columbia University, New York, NY. Available at: https://www.casacolumbia.org/supportcasa/sub-category.asp?CatalogVar=0&cID=12. Last accessed August 15, 2006.
6. Cicero T.J., and Inciardi J.A. Diversion and abuse of methadone prescribed for pain management. JAMA 293 (2005) 297-298
7. Compton W.M., Grant B.F., Colliver J.D., Glantz M.D., and Stinson F.S. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA 291 (2004) 2114-2121
8. Compton W., and Volkow N.D. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 81 (2006) 103-107
9. Cottler L.B., Grant B.F., Blaine J., Mavreas V., Pull C.B., Hasin D., Compton W.M., Rubio-Stipec M., and Mager D. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend. 47 (1997) 195-205
10. Drug Enforcement Administration (DEA), 2002. Drug intelligence brief: Oxycontin: Pharmaceutical division. Drug Enforcement Administration, Washington, DC.
11. Forman R.F. Availability of opioids on the Internet. JAMA 290 (2003) 889
12. Forman R.F., Woody G.E., McLellan T., and Lynch K.G. The availability of web sites offering to sell opioid medications without prescriptions. Am. J. Psychiatry 163 (2006) 1233-1238
13. Grant B.F. Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey. J. Subst. Abuse 8 (1996) 195-210
14. Grant B.F. Toward an alcohol treatment model: a comparison of treated and untreated respondents with DSM-IV alcohol use disorders in the general population. Alcohol. Clin. Exp. Res. 20 (1996) 372-378
15. Grant B.F., Dawson D.A., Stinson F.S., Chou P.S., Kay W., and Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 71 (2003) 7-16
16. Grant B.F., Harford T.C., Dawson D.A., Chou S.P., Dufour M., and Pickering R.P. Prevalence of DSM-IV alcohol abuse and dependence: United States, 1992. Alcohol Health Res. World 18 (1992) 243-248
17. Grant B.F., Harford T.C., Dawson D.A., Chou P.S., and Pickering R.P. The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 39 (1995) 37-44
18. Grant, B., Moore, T.C., Shepard, J., Kaplan, K., 2003a. Source and Accuracy Statement: Wave 1 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD. Available at http://niaaa.census.gov/pdfs/source_and_accuracy_statement.pdf. Last accessed on August 15, 2006.
19. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W.M., Pickering R.P., and Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 61 (2004) 807-816
20. Gureje O., Von Korff M., Simon G.E., and Gater R. Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA 280 (1998) 147-151
21. Lucas P.B., Gardner D.L., Wolkowitz O.M., Tucker E.E., and Cowdry R.W. Methylphenidate-induced cardiac arrhythmias. N. Engl. J. Med. 315 (1986) 1485
22. McCabe S.E. Correlates of nonmedical use of prescription benzodiazepine anxiolytics: results from a national survey of U.S. college students. Drug Alcohol Depend. 79 (2005) 53-62
23. McCabe S.E., Teter C.J., and Boyd C.J. The use, misuse and diversion of prescription stimulants among middle and high school students. Subst. Use Misuse 39 (2004) 1095-1116
24. Murray M.J., DeRuyter M.L., and Harrison B.A. Opioids and benzodiazepines. Crit. Care Clin. 11 (1995) 849-873
25. O'Brien C.P. Benzodiazepine use, abuse, and dependence. J. Clin. Psychiatry 66 Suppl. 2 (2005) 28-33
26. Olfson M., Gameroff M.J., Marcus S.C., and Jensen P.S. National trends in the treatment of attention deficit hyperactivity disorder. Am. J. Psychiatry 160 (2003) 1071-1077
27. Olfson M., Kessler R.C., Berglund P.A., and Lin E. Psychiatric disorder onset and first treatment contact in the United States and Ontario. Am. J. Psychiatry 155 (1998) 1415-1422
28. Parran Jr. T. Prescription drug abuse. A question of balance. Med. Clin. North Am. 81 (1997) 967-978
29. Research Triangle Institute, 2004. Software for Survey Data Analysis (SUDAAN) Version 9.0. Research Triangle Institute, Research Triangle Park, NC.
30. Shader R.I., and Greenblatt D.J. Use of benzodiazepines in anxiety disorders. N. Engl. J. Med. 328 (1993) 1398-1405
31. Simoni-Wastila L., Ritter G., and Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst. Use Misuse 39 (2004) 1-23
32. Simoni-Wastila L., and Strickler G. Risk factors associated with problem use of prescription drugs. Am. J. Public Health 94 (2004) 266-268
33. Stinson F.S., Grant B.F., Dawson D.A., Ruan W.J., Huang B., and Saha T. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 80 (2005) 105-116
34. Stoops W.W., Lile J.A., Fillmore M.T., Glaser P.E., and Rush C.R. Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl.) 177 (2005) 349-355
35. Substance Abuse and Mental Health Services Administration (SAMHSA) Office of Applied Studies, 2003. Results from the 2002 National Survey on Drug Use and Health: National findings. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD.
36. Swanson J.M., and Volkow N.D. Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD. Behav. Brain Res. 130 (2002) 73-78
37. Wang P.S., Berglund P., Olfson M., Pincus H.A., Wells K.B., and Kessler R.C. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62 (2005) 603-613
38. Wilens T.E., Faraone S.V., Biederman J., and Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111 (2003) 179-185
39. Zacny J., Bigelow G., Compton P., Foley K., Iguchi M., and Sannerud C. College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 69 (2003) 215-232